Severe infections raise dementia risk in large Finnish study

A study of over 375,000 Finns has linked hospital treatment for severe infections like cystitis and pneumonia to a higher risk of developing dementia within five to six years. Researchers identified 29 conditions associated with at least a 20 percent increased risk, with infections playing a key role. The findings suggest that preventing such infections could help modify dementia risk.

Researchers led by Pyry Sipilä at the University of Helsinki analyzed health records of 62,555 people aged 65 or older who received a dementia diagnosis between 2017 and 2020. They compared these individuals to 312,772 matched controls without dementia, tracking diagnoses and hospitalizations over the prior two decades, including matching for age, sex, education, and marital status. The study, published in PLOS Medicine (DOI: 10.1371/journal.pmed.1004688), found 29 conditions linked to at least a 20 percent higher dementia risk about five to six years later. Most were non-infectious, affecting the heart or brain, but cystitis—a bacterial urinary tract infection—and unspecified bacterial infections stood out. Further analysis showed these infections drove much of the elevated risk. Sipilä noted that infection-related inflammation might breach the blood-brain barrier, causing damage, and pointed to emerging evidence that vaccines for shingles and flu could lower dementia odds. For early-onset dementia before age 65, Parkinson's disease and head trauma posed the highest risks, but infections such as gastroenteritis, infectious or unspecified colitis, pneumonia, tooth decay, and unspecified bacterial infections roughly doubled the risk. Kuan-Ching Wu at Emory University, who was not involved, said the results suggest dementia risk may be partially modifiable through infection prevention, like hydration and prompt UTI treatment in older adults, where symptoms can mimic confusion. Gill Livingston at University College London called it a high-quality study with biological plausibility supporting a potential causal link. Sipilä cautioned that correlations do not prove causation and called for intervention trials to test prevention strategies.

相关文章

Elderly woman holding glucosamine bottle with concerned look, medical documents on dementia study nearby
AI 生成的图像

Study links glucosamine use to faster progression from mild cognitive impairment to dementia

由 AI 报道 AI 生成的图像 事实核查

A University of Florida-led study reported an association between use of the joint-health supplement glucosamine and a higher risk of progressing from mild cognitive impairment to dementia, as well as higher mortality among patients already diagnosed with Alzheimer’s disease and related dementias. The researchers emphasized that the findings do not prove glucosamine causes cognitive decline and said the results should be tested in clinical trials.

A study involving 73 people with mild cognitive impairment or early dementia found that tailored treatment plans targeting nutritional deficiencies, infections and other factors led to significant cognitive improvements after nine months. Participants in the intervention group saw their overall cognitive scores rise by 13.7 points, while the control group declined by 4.5 points. The approach combines medical interventions with lifestyle changes like diet, exercise and cognitive training.

由 AI 报道

New research from the University of California San Diego shows that several common dementia risk factors affect women's cognitive performance more strongly than men's. The findings help explain why women account for nearly two thirds of Alzheimer's cases in the United States.

A new study shows that blood tests can detect signs of Alzheimer's several years before the disease develops. American researchers published the findings in The Lancet.

由 AI 报道

A new study has found that adults with higher vitamin D levels in their 30s and 40s tend to have lower levels of tau protein in their brains about 16 years later. Tau is a key biomarker associated with dementia. The research, published this week, highlights a potential modifiable risk factor for brain health.

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝